UPC - universe-pharmaceuticals-declining-sales-performance-concerns-loom

Deep-Dive Due Diligence AI Generated Probe of Universe Pharmaceuticals Inc. Ordinary Shares (UPC)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These auto-generated reports apply OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.

UPC_OUT_1 [2025-03-24 16:26:18 -0400] 2004 Bytes | 508 tokens | Cum: 508 tkns (6.35% of 8k)
==========================================================================

Booyah, my friends! It's already 4:26:16 PM on Mon Mar 24, 2025 -0400, and I've got my eyes locked on Universe Pharmaceuticals (UPC), pushing up to 4.3 from 3.524. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

Here's the first list of news for Universe Pharmaceuticals:

C1 - Mar-20-25 08:42AM - Universe Pharmaceuticals to conduct share consolidation
C2 - Mar-20-25 08:42AM 08:30AM - Universe Pharmaceuticals INC Announces Share Consolidation
C3 - Feb-25-25 04:10PM - Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report
C4 - Feb-03-25 04:10PM - Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request
C5 - Dec-10-24 05:00PM - Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
C6 - Dec-09-24 07:00AM - Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
C7 - Nov-13-24 08:00AM - Universe Pharmaceuticals INC Announces Share Consolidation
C8 - Nov-01-24 04:00PM - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Universe Pharmaceuticals (UPC)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

UPC_IN_2 [2025-03-24 16:26:18 -0400] 2 Bytes | 2 tokens | Cum: 510 tkns (6.38% of 8k)
==========================================================================

UPC_OUT_3 [2025-03-24 16:26:24 -0400] 629 Bytes | 178 tokens | Cum: 688 tkns (8.60% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**Universe Pharmaceuticals to conduct share consolidation**
Date: Mar-20-25 08:42AM
Source: (SeekingAlpha)
URL: https://seekingalpha.com/news/4422776-universe-pharmaceuticals-to-conduct-share-consolidation?utm_source=finviz.com&utm_medium=referral&feed_item_type=news

Error fetching article: 403 Client Error: Forbidden for url: https://seekingalpha.com/news/4422776-universe-pharmaceuticals-to-conduct-share-consolidation?utm_source=finviz.com&utm_medium=referral&feed_item_type=news

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

UPC_IN_4 [2025-03-24 16:26:24 -0400] 403 Bytes | 69 tokens | Cum: 757 tkns (9.46% of 8k)
==========================================================================

Universe Pharmaceuticals is set to conduct a share consolidation, as reported by SeekingAlpha. Further details about the consolidation are not available at this time due to technical difficulties retrieving the full article. Share consolidation, also known as a reverse stock split, is a corporate action that reduces the number of outstanding shares, which can potentially increase the per-share price.

UPC_OUT_5 [2025-03-24 16:26:25 -0400] 841 Bytes | 225 tokens | Cum: 982 tkns (12.28% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-20T13:18:00Z - Universe Pharmaceuticals Plans To Effect Share Consolidation...
A2 - 2025-03-20T12:33:22Z - Universe Pharmaceuticals INC Announces Share Consolidation...
A3 - 2025-03-20T12:42:57Z - Universe Pharmaceuticals to conduct share consolidation (NASDAQ:UPC)...
A4 - 2025-03-20T12:39:35Z - Universe Pharmaceuticals INC Announces Share Consolidation...
A5 - 2025-03-20T12:41:04Z - Universe Pharmaceuticals INC Announces Share Consolidation...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

UPC_IN_6 [2025-03-24 16:26:25 -0400] 2 Bytes | 2 tokens | Cum: 984 tkns (12.30% of 8k)
==========================================================================

UPC_OUT_7 [2025-03-24 16:26:31 -0400] 1038 Bytes | 275 tokens | Cum: 1259 tkns (15.74% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Universe Pharmaceuticals Plans To Effect Share Consolidation**Date: 2025-03-20Source: {'uri': 'finanznachrichten.de', 'dataType': 'news', 'title': 'FinanzNachrichten.de'}URL: https://www.finanznachrichten.de/nachrichten-2025-03/64880654-universe-pharmaceuticals-plans-to-effect-share-consolidation-020.htmBEIJING (dpa-AFX) - Universe Pharmaceuticals (UPC) said it plans to effect a share consolidation of 40 ordinary shares with par value of $0.28125 per share each in the companys issued and unissued share capital into one ordinary share with par value of $11.25. As a result, each 40 pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.

The share Consolidation will be made effective on March 24, 2025. Beginning with the opening of trading on March 24, 2025, t

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

UPC_IN_8 [2025-03-24 16:26:31 -0400] 384 Bytes | 81 tokens | Cum: 1340 tkns (16.75% of 8k)
==========================================================================

Universe Pharmaceuticals (UPC) has announced its plan to consolidate 40 ordinary shares with a par value of $0.28125 each into one ordinary share with a par value of $11.25. This consolidation will automatically convert each 40 pre-consolidation ordinary shares into one issued and outstanding ordinary share. The share consolidation is expected to become effective on March 24, 2025.

UPC_OUT_9 [2025-03-24 16:26:32 -0400] 1034 Bytes | 290 tokens | Cum: 1630 tkns (20.38% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-11-01T20:00:00Z - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
B2 - 2024-02-20T18:21:11Z - Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B3 - 2024-02-20T13:09:16Z - Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
B4 - 2024-01-08T18:36:30Z - Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B5 - 2023-08-04T12:30:00Z - Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
B6 - 2023-07-27T14:15:00Z - Universe Pharmaceuticals INC Announces Share Consolidation

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

UPC_IN_10 [2025-03-24 16:26:32 -0400] 2 Bytes | 2 tokens | Cum: 1632 tkns (20.40% of 8k)
==========================================================================

UPC_OUT_11 [2025-03-24 16:26:38 -0400] 1040 Bytes | 255 tokens | Cum: 1887 tkns (23.59% of 8k)
==========================================================================

Showing B3 (chunk 1 of 2): B3:
**Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/02/37210416/why-discover-financial-services-shares-are-trading-higher-by-around-11-here-are-20-stocks-moving-preShares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading.
Capital One Financial Corp (NYSE: COF) announced its plans to purchase Discover Financial Services, marking a pivotal $35.3 billion all-stock transaction.
As per the terms of the deal, Discover shareholders are slated to receive 1.0192 shares of Capital One for every share they hold, translating to a 26% premium over Discover's last closing price.
Discover Financial Services shares jumped 11.2% to $122.88 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gain

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

UPC_IN_12 [2025-03-24 16:26:38 -0400] 424 Bytes | 96 tokens | Cum: 1983 tkns (24.79% of 8k)
==========================================================================

Discover Financial Services shares are trading at an increased rate due to a proposed purchase by Capital One Financial Corp. The deal, which is worth $35.3 billion in an all-stock transaction, will give Discover shareholders 1.0192 shares of Capital One for each of their shares, a 26% premium over Discover's last closing price. This news led to a sharp rise in Discover's shares by 11.2% to $122.88 in pre-market trading.

UPC_OUT_13 [2025-03-24 16:26:39 -0400] 238 Bytes | 59 tokens | Cum: 2042 tkns (25.52% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

UPC_IN_14 [2025-03-24 16:26:39 -0400] 13 Bytes | 3 tokens | Cum: 2045 tkns (25.56% of 8k)
==========================================================================

To assist you

UPC_OUT_15 [2025-03-24 16:26:53 -0400] 3314 Bytes | 840 tokens | Cum: 2885 tkns (36.06% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: Universe Pharmaceuticals Inc. Ordinary Shares
Market Cap: 1503484.55
Shares Outstanding: 380629
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4.39
Average Volume: 64104.97
30-Day High: 6.392
30-Day Low: 3.524
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

UPC_IN_16 [2025-03-24 16:26:53 -0400] 1110 Bytes | 244 tokens | Cum: 3129 tkns (39.11% of 8k)
==========================================================================

1) Brief Summary: The financial data for Universe Pharmaceuticals Inc. reveals a concerning trend. The company has shown a significant decrease in performance over the past weeks, months, and quarter, with metrics such as SMA50, SMA200, and Perf Month all indicating notable declines. The company's market cap is relatively low at 0.95M, and shares outstanding are also low at 0.22M. The company's sales have also been declining, with a Q/Q sales decrease of -30.23%. Further, the company's debt to equity ratio stands at 0.24, indicating that the company is using debt to finance its assets. Importantly, there is an absence of detailed financial data, making a comprehensive analysis challenging.

2) MARKET_SCORE[15]: Given the negative trends in the company's performance and the absence of key financial data, the likelihood of an upward move appears low.

3) PRICE_TARGET[$3.50]: Considering the company's current and past performance, the price target is projected to decrease from its current price of $4.39.

4) AI_RPT_HEADLINE: "Universe Pharmaceuticals: Declining Sales, Performance Concerns Loom"

UPC_OUT_17 [2025-03-24 16:26:58 -0400] 676 Bytes | 167 tokens | Cum: 3296 tkns (41.20% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

UPC_IN_18 [2025-03-24 16:26:58 -0400] 384 Bytes | 77 tokens | Cum: 3373 tkns (42.16% of 8k)
==========================================================================

As a financial analyst, I would choose -> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes. These documents provide a comprehensive overview of a company's financial health, risk factors, and recent changes in business operations. Having more of this information would definitely improve the accuracy and confidence of my financial analysis.

UPC_IN_19 [2025-03-24 16:26:59 -0400] 126 Bytes | 29 tokens | Cum: 3402 tkns (42.52% of 8k)
==========================================================================

====================================
[2025-03-24 13:26:59] # Analysis Completed
Elapsed Time: 43.21 seconds